Context 68 Gallium prostate-specific membrane antigen positron emission tomography (68
Ga-PSMA PET) is an emerging imaging modality for assessment of prostate cancer. Recent …

Radiotherapy and radiation oncology play a key role in the clinical management of patients
suffering from oncological diseases. In clinical routine, anatomic imaging such as contrast …

Importance In retrospective studies, 68 Ga-PSMA-11 positron emission tomographic (PET)
imaging improves detection of biochemically recurrent prostate cancer compared with …

Purpose: The summary presented herein represents Part I of the two-part series dedicated to
Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline discussing prognostic and …

Purpose: Systemic androgen-signaling inhibition added to ongoing androgen-deprivation
therapy (ADT) improved clinical outcomes in patients with nonmetastatic castration-resistant …

Prostate cancer is the most common cancer diagnosis in men in the United States and a
leading cause of cancer-related morbidity and mortality (1). It can exist along a wide …

Currently, different radiometals are in use for imaging and therapy in nuclear medicine:
68Ga and 111In are examples of nuclides for positron emission tomography (PET) and …

Background Prostate-specific membrane antigen (PSMA) PET is highly sensitive in
identifying disease recurrence in men with biochemical recurrence of prostate cancer (BCR) …

The impact of prostate-specific membrane antigen (PSMA) PET/CT on management of
prostate cancer (PCa) patients with biochemical recurrence (BCR) is well established …

Prostate-specific membrane antigen (PSMA) ligand PET induces management changes in
patients with prostate cancer. We aim to better characterize the impact of 68Ga-PSMA-11 …